It's the first model to use BMW's Gen6 platform - promising more range and greater efficiency ...

Whether you love or hate the look of the BMW iX, it was undeniably ambitious for an electric SUV. BMW’s first bespoke EV platform since the futuristic i3 remains unique to the iX and its part ...

BMW’s first electric car, the BMW i3, had a gorgeous and avant-garde cabin filled with unconventional materials. The iX takes this theme and runs with it, creating an interior that feels unlike almost ...

The European Commission (EC) will now review the CHMP recommendation, and a decision on the label extension application of IXCHIQ® in the European Union (EU), Norway, Liechtenstein and Iceland is ...

The European Medicines Agency’s CHMP regulatory committee gave a positive opinion to add a self-administration option for asthma injection Fasenra (benralizumab), based on a new delivery method ...

The Committee for Medicinal Products for Human Use (CHMP) has also recommended J&J’s Stelara (ustekinumab) to treat paediatric patients weighing at least 40kg with moderately to severely active CD, ...

The BMW iX is unquestionably the most radical and technologically advanced BMW electric car since the i3 was revealed more than a decade ago. In fact, you can see the lessons learned from the ...

The BMW iX is unquestionably the most radical and technologically advanced BMW electric car since the i3 was revealed more than a decade ago. In fact, you can see the lessons learned from the ...

It’s a sales success in most territories, and the iX has become a familiar sight on UK roads. Now we get a mid-life upgrade, which offers a judicious visual overhaul and a number of important ...

NORTH GEORGIA — Dry and windy conditions over the weekend fueled dozens of wildfires across North Georgia, burning nearly 2,500 acres before winds subsided. Fires in Lumpkin and Rabun counties ...

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency has adopted a positive opinion for the label expansion of Fabhalta ...